Adrenal Insufficiency: Clinical Trials

29 trials for Adrenal Insufficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 5 unknown, 3 recruiting, 3 withdrawn. 29 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 429Completed 14, Unknown 5, Recruiting 3, Withdrawn 3, Not yet recruiting 2, Active not recruiting 1, Enrolling by invitation 1

Follow Adrenal Insufficiency: new trials by email Literature Review of Adrenal Insufficiency trials Research Report on Adrenal Insufficiency

Trials (filtered) newest first · largest first

All 29 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hydrocortisone Versus Methylprednisolone for the Treatment of Glucocorticoid-Induced Adrenal Insufficiency
Patients will receive 3 mg of methylprednisolone once daily. The dose is administered in the morning (1 ½ tablets of 2 mg Medrol after breakfast)., Patients will receive 15 mg of hydrocortisone daily. The dose is split into 10 mg in the morning after breakfast and 5 mg after 6-7 hours. - Adrenal Insufficiency
Phase 4Not yet recruitingUniversity Medical Centre Ljubljana662026-09-012026-07-14
Combination Osilodrostat and Cabergoline in Cushing's Disease
osilodrostat, osilodrostat and cabergoline - Cushing Disease Due to Increased ACTH Secretion
Phase 4Enrolling by invitationUniversity of Basrah502026-05-112026-05-22
A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab
Oral Corticosteroid Tapering Schedule, Ravulizumab, Prednisone/Prednisolone - Generalized Myasthenia Gravis, gMG
Phase 4RecruitingAlexion Pharmaceuticals, Inc.752026-03-042026-04-09
Comparison of Glucocorticoid Tapering Schedules in Rheumatoid Arthritis
Prednisolone - Rheumatoid Arthritis (RA)
Phase 4Not yet recruitingSeoul National University Hospital2062025-12-012025-11-25
Tolerability and Acceptance of Two Oral Hydrocortisone Compounding Formulation for Pediatrics
3D printed chewable formulation of hydrocortisone, Oral suspension of hydrocortisone - Adrenal Insufficiency
Phase 4UnknownHospital Universitari Vall d'Hebron Research Institute352024-09-012024-05-30
Treating Leg Symptoms in Women With X-linked Adrenoleukodystrophy
Pramipexole, Placebo - Adrenoleukodystrophy, Restless Legs Syndrome
Phase 4Active not recruitingMassachusetts General Hospital242023-04-012026-07-01
Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal Insufficiency
Hydrocortisone, Placebo for hydrocortisone - Adrenal Insufficiency, Polymyalgia Rheumatica
Phase 4RecruitingMarianne Christina Klose2502022-06-072026-03-16
The Effects of Two Brands of Hydrocortisone Injected Intramuscularly Into Deltoid and Thigh Muscles
Solu-Cortef 100 MG Injection, Hydrocortisone 100mg/ml - Addison's Disease
Phase 4UnknownThe London Clinic82022-03-142022-04-27
Hydrocortisone and Placebo in Patients With Symptoms of Adrenal Insufficiency After Cessation of Glucocorticoid Treatment
Hydrocortisone, Placebo - Adrenal Insufficiency, Polymyalgia Rheumatica (PMR)
Phase 4RecruitingMarianne Andersen1002022-02-012025-12-22
A Study of Markers of Glucocorticoid Effects in Patients With Addisons Disease (DOSCORT)
Betamethasone - Addison Disease
Phase 4CompletedGöteborg University302021-03-022025-04-24
Effects of High Intensity Statin Therapy on Steroid Hormones and Vitamin D in Type 2 Diabetic Men
Atorvastatin 40 Mg Oral Tablet - Diabetes Mellitus, Type 2, Dyslipidemia Associated With Type II Diabetes Mellitus
Phase 4CompletedHopital La Rabta1042021-03-012023-04-10
Salivary Cortisol Measurement in Corticotrope Deficiency Substitution With Hydrocortisone.
Hydrocortisone (capsule) - Adrenal Insufficiency
Phase 4CompletedUniversity Tunis El Manar402021-01-012022-07-13
Comparison of Intramuscular and Intravenous ACTH Stimulation Test in Normal Volunteers
Cosyntropin - Adrenal Insufficiency
Phase 4WithdrawnJohns Hopkins University2019-07-012019-05-10
Optimising Steroid Replacement in Patients With Adrenal Insufficiency
Modified release hydrocortisone - Adrenal Insufficiency
Phase 4UnknownThe Adelaide and Meath Hospital, incorporating The National Children's Hospital602017-09-052017-09-14
Modified-release Compared to Conventional Hydrocortisone on Diurnal Fatigue in Secondary Hypoadrenalism
Hydrocortisone, Plenadren - Adrenal Insufficiency
Phase 4UnknownUlla Feldt-Rasmussen302016-10-012017-02-23
Steroid Use in Pediatric Fluid and Vasoactive Infusion Dependent Shock - Pilot Study
Hydrocortisone, Placebo - Shock
Phase 4CompletedChildren's Hospital of Eastern Ontario572014-07-012019-03-26
Dual RElease Hydrocortisone Versus conventionAl Glucocorticoid replaceMent Therapy in Hypocortisolism (DREAM)
Plenadren, Conventional glucocorticoid therapy - Primary Adrenal Insufficiency, Secondary Adrenal Insufficiency
Phase 4CompletedUniversity of Roma La Sapienza892014-03-012019-04-25
Evaluation of Efficacy and Hypothalamus-pituitary-adrenal Axis Suppression Due to Corticosteroids Intrabursal Injection
methylprednisolone acetate, Triamcinolone Acetonide - Tendinopathy, Adrenal Insufficiency
Phase 4CompletedIstituto Ortopedico Rizzoli442012-03-012014-09-01
Hydrocortisone Replacement in Patients With Secondary Adrenal Insufficiency (SUPREME CORT)
Hydrocortisone - Adrenal Insufficiency
Phase 4CompletedUniversity Medical Center Groningen632012-02-012014-07-14
Revival of Stem Cells in Addison's Study
depot tetracosactide - Adrenal Failure
Phase 4CompletedNewcastle University132010-09-012013-02-06

Showing 20 of 29. Sign in to see all of them.

Narrower conditions

Addison Disease (5)  ·  Giant Cell Arteritis (2)  ·  Hypopituitarism (2)  ·  Polymyalgia Rheumatica (2)  ·  Sepsis (2)  ·  Adrenoleukodystrophy (1)  ·  Arthritis, Rheumatoid (1)  ·  Burns (1)  ·  Coronary Artery Disease (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Eunuchism (1)  ·  Fatigue (1)  ·  Hyperandrogenism (1)  ·  Hypertension (1)

Broader conditions

Adrenal Gland Diseases (29)  ·  Endocrine System Diseases (29)  ·  Autoimmune Diseases (9)  ·  Immune System Diseases (9)  ·  Nervous System Diseases (7)  ·  Brain Diseases (6)  ·  Central Nervous System Diseases (6)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Cardiovascular Diseases (4)  ·  Musculoskeletal Diseases (4)  ·  Pathologic Processes (4)  ·  Vascular Diseases (4)  ·  Autoimmune Diseases of the Nervous System (3)  ·  Connective Tissue Diseases (3)

Interventions

Hydrocortisone (12)  ·  Cosyntropin (3)  ·  Prednisolone (3)  ·  Etomidate (2)  ·  Prednisone (2)  ·  Propofol (2)  ·  hydrocortisone hemisuccinate (2)  ·  Atorvastatin (1)  ·  Betamethasone (1)  ·  Cabergoline (1)  ·  Capsules (1)  ·  Cortisone (1)  ·  Dexamethasone (1)  ·  Fludrocortisone (1)  ·  Glucocorticoids (1)

Sponsors

Alexion Pharmaceuticals, Inc. (1)  ·  CAMC Health System (1)  ·  Cardiff University (1)  ·  Centre Hospitalier Universitaire de Saint Etienne (1)  ·  Children's Hospital of Eastern Ontario (1)  ·  Göteborg University (1)  ·  Hopital La Rabta (1)  ·  Hospices Civils de Lyon (1)  ·  Hospital Universitari Vall d'Hebron Research Institute (1)  ·  Insel Gruppe AG, University Hospital Bern (1)  ·  Istituto Ortopedico Rizzoli (1)  ·  Johns Hopkins University (1)  ·  Marianne Andersen (1)  ·  Marianne Christina Klose (1)  ·  Massachusetts General Hospital (1)

Countries

Italy (3)  ·  United Kingdom (3)  ·  Canada (2)  ·  Denmark (2)  ·  France (2)  ·  Netherlands (2)  ·  Switzerland (2)  ·  Tunisia (2)  ·  United States (2)  ·  Germany (1)  ·  Iraq (1)  ·  Ireland (1)  ·  Japan (1)  ·  Slovenia (1)  ·  Spain (1)

Top investigators

Abbas A Mansour (1)  ·  Aled Rees, MB BCh, PhD (1)  ·  Andrea M Isidori, MD, PhD (1)  ·  Florian S Eichler, MD (1)  ·  Gudmundur Johannsson, Prof., MD (1)  ·  Haider A Alidrisi (1)  ·  Hector Wong, MD (1)  ·  Ibrahim H Hussein, MD (1)  ·  James D McNally, MD, PhD (1)  ·  Jill A Osborn, MD (1)  ·  John A Bethea, Pharm.D. (1)

Results publications

PMID 10321661, PMID 10697064, PMID 10923728, PMID 12186604, PMID 19383806, PMID 22112807, PMID 23761380, PMID 24170102, PMID 24944332, PMID 25619170, PMID 25705800, PMID 26646751, PMID 26914224, PMID 27153945, PMID 27490921, PMID 28521880, PMID 28623938, PMID 29229498, PMID 29846607, PMID 29982583, PMID 3029157, PMID 3306374, PMID 37339332, PMID 38764377, PMID 4101232, PMID 41638742, PMID 42276802, PMID 6270176, PMID 6384785, PMID 7600840, PMID 7634816, PMID 7638758, PMID 8815944, PMID 8855809, PMID 9559600

NIH funding

2009 (1), 2014 (1), 2016 (1)